跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ACTIQ fentanyl 400microgram (as citrate) lozenge with integral applicator blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
ACTIQ fentanyl 400microgram (as citrate) lozenge with integral applicator blister pack
Approved
STANDARD
ACTIQ fentanyl 400microgram (as citrate) lozenge with integral applicator blister pack
Teva Pharma Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
681f1a2948a3682d
Company
Teva Pharma Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
681f1a2948a3682d
Product Name
ACTIQ fentanyl 400microgram (as citrate) lozenge with integral applicator blister pack
Artg Id
91600
Artg Name
ACTIQ fentanyl 400microgram (as citrate) lozenge with integral applicator blister pack
Sponsor
Teva Pharma Australia Pty Ltd
Company Detail Path
/organization/teva-pharma-australia-pty-ltd
Artg Date
2002-11-15
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/6ce3e4d9b323a3217c4c0c31a99e7fc2.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/e63a472c50691171dc6fd79b995683a2.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
681f1a2948a3682d
Type
Standard
Back to TGA Approvals